| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CLINICAL PHARMACOLOGY & THERAPEUTICS LetPub Score 7.8
50 ratings
Rate
Reputation 8.8 Influence 7.1 Speed 7.1 | ||||||||||||||||||||
| 期刊簡稱 | CLIN PHARMACOL THER | ||||||||||||||||||||
| ISSN | 0009-9236 | ||||||||||||||||||||
| E-ISSN | 1532-6535 | ||||||||||||||||||||
| h-index | 173 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 7.90%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | http://www.nature.com/clpt/index.html | ||||||||||||||||||||
| 在線稿件提交 | http://cpt.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||
| 出版商 | Wiley-Blackwell | ||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||
| 出版國/地區 | UNITED STATES | ||||||||||||||||||||
| 發行頻率 | 月刊 | ||||||||||||||||||||
| 創刊年 | 1960 | ||||||||||||||||||||
| 每年文章數 | 231每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 43.17% | ||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q1
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0009-9236%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: About 25% | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [CLINICAL PHARMACOLOGY & THERAPEUTICS] 的評論 | 撰寫評論 |
| 作者: QHANN 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-05-24 11:53:11 評論於 The editor is very friendly, and it takes about three to four months from submission to acceptance.  (0) 讚！ | QHANN  |
| 作者: richbird 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2021-12-01 11:52:22 評論於 This magazine has rejected two of my articles. The first time was a quick rejection, which was good because it didn't delay me from submitting to other magazines. The second time they rejected my submission, they offered me an option: they could help me submit it to their CPT: Pharmacometrics & Systems Pharmacology. However, they mentioned that this might be a lower impact factor journal and it would require a high page charge. Overall, despite being rejected twice, I have a good impression of this magazine. (1) 讚！ | richbird |
| 作者: 叫什么名字才能不被注册 領域: 医学 審稿時間: 3.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-11-15 14:19:03 評論於 Excuse me, I would like to ask if there is a review fee. Is the review fee for external review or for the editor's review? (0) 讚！ | 叫什么名字才能不被注册 |
| 作者: Regulus 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2021-07-26 10:12:44 評論於 Top journals in the field of clinical pharmacology, although they have a relatively low impact factor, are difficult to be accepted due to high innovation requirements. Very few articles are contributed by Chinese researchers. My first submission was rejected, so I will submit again in the future with high-quality articles. (0) 讚！ | Regulus |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
